May 13, 2020 In Victory Over Polio, Hope for the Battle Against COVID-19

Medicine’s great triumph over polio holds out hope we can do the same for COVID-19, two researchers say.

May 12, 2020 COVID-19: UVA Discovery Spurs Clinical Trial of Antidepressant

The drug has shown promise for stopping dangerous overreactions of the immune system, a concern in patients with severe COVID-19.

May 11, 2020 Telehealth Tools Developed for Ebola Improve COVID Care

The telehealth tools allow doctors to provide personal, high-quality care while conserving vital personal protective equipment and reducing infection risks.

May 8, 2020 UVA Health Reopens for In-Person Care

UVA Health is ramping up access to both inpatient and outpatient care with robust safety measures in place to protect the health of patients and team members.

May 6, 2020 Focused Ultrasound Opening Brain to Impossible Treatments

Focused ultrasound, the researchers hope, could revolutionize treatment for conditions from Alzheimer’s to brain tumors and even stroke.

May 4, 2020 UVA Health Trial to Test Convalescent Plasma as Potential COVID-19 Treatment

UVA Health is testing the use of plasma from patients who have recovered from COVID-19 as a potential treatment for inpatients with the disease.

May 2, 2020 Drug Tested at UVA Cleared as 1st COVID-19 Treatment

The antiviral drug, remdesivir, becomes the first treatment authorized to battle life-threatening COVID-19.

April 30, 2020 COVID-19: Drug Tested at UVA Speeds Recovery

The antiviral helped patients with advanced cases recover 31% faster than patients who received a placebo, the National Institutes of Health reports.

April 29, 2020 Team-Up Targets Spinal Cord Injuries

Two top scientists are seeking answers to questions about spinal cord injuries that have long frustrated the development of effective treatments.

April 28, 2020 UVA Health Enacting Changes in Response to COVID-19 Financial Impact

UVA Health is taking steps to mitigate the financial effects of COVID-19 and safeguard its ability to serve the community.